Craig-Hallum analyst John Wilkin initiated coverage of Adaptive Biotechnologies (ADPT) with a Buy rating and $15 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADPT:
- Adaptive Biotechnologies Holds Annual Shareholders Meeting
- Adaptive Biotechnologies highlights new data at ASCO Meeting, EHA Congress
- Adaptive Biotechnologies price target raised to $13 from $11 at Piper Sandler
- Biotech Alert: Searches spiking for these stocks today
- Adaptive Biotechnologies price target raised to $9 from $7 at Morgan Stanley
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue